Veracyte, Inc.VCYTNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank56
3Y CAGR-33.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-33.3%/yr
vs +0.6%/yr prior
Acceleration
-33.9pp
Decelerating
Percentile
P56
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 13.05% |
| Q3 2025 | 535.57% |
| Q2 2025 | -281.40% |
| Q1 2025 | -30.44% |
| Q4 2024 | -65.26% |
| Q3 2024 | 160.90% |
| Q2 2024 | 198.93% |
| Q1 2024 | 86.89% |
| Q4 2023 | -11.87% |
| Q3 2023 | -294.22% |
| Q2 2023 | 23.31% |
| Q1 2023 | -93.69% |
| Q4 2022 | 44.01% |
| Q3 2022 | 9.81% |
| Q2 2022 | 29.61% |
| Q1 2022 | -23.64% |
| Q4 2021 | 26.07% |
| Q3 2021 | -123.19% |
| Q2 2021 | 83.54% |
| Q1 2021 | -462.62% |
| Q4 2020 | -98.52% |
| Q3 2020 | 63.21% |
| Q2 2020 | 9.42% |
| Q1 2020 | -48.83% |
| Q4 2019 | -364.95% |
| Q3 2019 | 43.13% |
| Q2 2019 | -49.98% |
| Q1 2019 | 32.38% |
| Q4 2018 | 28.97% |
| Q3 2018 | 27.26% |
| Q2 2018 | 33.93% |
| Q1 2018 | -48.16% |
| Q4 2017 | 5.09% |
| Q3 2017 | 3.65% |
| Q2 2017 | 12.08% |
| Q1 2017 | -104.71% |
| Q4 2016 | 24.85% |
| Q3 2016 | 53.44% |
| Q2 2016 | -7.62% |
| Q1 2016 | -22.64% |